Leica Biosystems To Acquire Aperio

Leica Biosystems To Acquire Aperio PR Newswire NUSSLOCH, Germany and VISTA, California, Aug. 21, 2012 NUSSLOCH, Germany and VISTA, California, Aug. 21, 2012 /PRNewswire/ -- Leica Biosystems announced that an affiliate has entered into a definitive agreement to acquire Aperio, a leading provider of ePathology solutions. Aperio will be integrated into Leica Biosystems, a leader in anatomical pathology solutions. Together, the two businesses will leverage each other's strengths to grow and expand digital pathology into the global Life Science and Healthcare markets. The integrated business will provide industry leading solutions in each step of the anatomical pathology workflow, from sample preparation and staining, to imaging and reporting. The company will continue to offer both the Aperio and the existing Leica portfolio of Digital Pathology solutions, so that customers will enjoy more freedom to choose a solution that meets their individual needs. Aperio is a global leader in digital pathology, with the largest installed base of systems in both Life Science and Healthcare. Aperio ePathology Solutions include whole slide scanners, a NETWORK solution that enables remote, real- time viewing and easy distribution of images for peer review, collaboration and consultation. Its PRECISION solution provides pathologists with easy-to-use quantitative image analysis to improve research and clinical productivity, reproducibility, and consistency.